Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug. It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea. Reference standards of Rofecoxib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Rofecoxib - API Standards [catalogue_number] => PA 18 95000 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 314.36 [form] => C17H14O4S [cas] => 162011-90-7 [pslug] => 162011-90-7-rofecoxib-api-pa1895000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 18 95000
CAS :
Molecular Formula : C17H14O4S
Molecular Weight : 314.36
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....